Cubist Systematic Strategies’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,486
| Closed | -$1.76M | – | 4027 |
|
|
2023
Q3 | $1.7M | Sell |
11,486
-213,846
| -95% | -$38.7M | 0.01% | 1485 |
|
|
2023
Q2 | $49.2M | Buy |
225,332
+200,575
| +810% | +$44.7M | 0.33% | 20 |
|
|
2023
Q1 | $5.42M | Sell |
24,757
-100,321
| -80% | -$21.8M | 0.03% | 858 |
|
|
2022
Q4 | $26M | Buy |
125,078
+125,068
| +1,250,680% | +$27.5M | 0.15% | 78 |
|
|
2022
Q3 | $2K | Sell |
10
-1,043
| -99% | -$237K | ﹤0.01% | 4353 |
|
|
2022
Q2 | $221K | Sell |
1,053
-19,863
| -95% | -$4.23M | ﹤0.01% | 3641 |
|
|
2022
Q1 | $5.07M | Buy |
20,916
+99
| +0.5% | +$23.9K | 0.04% | 719 |
|
|
2021
Q4 | $5.42M | Sell |
20,817
-5,709
| -22% | -$1.48M | 0.05% | 597 |
|
|
2021
Q3 | $6.99M | Buy |
+26,526
| New | +$7.25M | 0.09% | 302 |
|
|
2021
Q2 | – | Sell |
-25,150
| Closed | -$4.88M | – | 3070 |
|
|
2021
Q1 | $4.88M | Sell |
25,150
-6,423
| -20% | -$1.29M | 0.06% | 470 |
|
|
2020
Q4 | $6.71M | Sell |
31,573
-48,754
| -61% | -$9.72M | 0.09% | 297 |
|
|
2020
Q3 | $13.8M | Buy |
80,327
+73,417
| +1,062% | +$13.6M | 0.2% | 66 |
|
|
2020
Q2 | $1.33M | Sell |
6,910
-4,164
| -38% | -$681K | 0.02% | 1018 |
|
|
2020
Q1 | $1.63M | Sell |
11,074
-3,970
| -26% | -$632K | 0.04% | 561 |
|
|
2019
Q4 | $2.33M | Sell |
15,044
-42,357
| -74% | -$6.1M | 0.04% | 664 |
|
|
2019
Q3 | $7.75M | Buy |
57,401
+54,807
| +2,113% | +$7.18M | 0.15% | 167 |
|
|
2019
Q2 | $317K | Buy |
+2,594
| New | +$287K | 0.01% | 1764 |
|
|
2019
Q1 | – | Sell |
-10,400
| Closed | -$1.18M | – | 2396 |
|
|
2018
Q4 | $1.18M | Sell |
10,400
-7,257
| -41% | -$778K | 0.06% | 483 |
|
|
2018
Q3 | $2.04M | Buy |
17,657
+2,586
| +17% | +$283K | 0.11% | 210 |
|
|
2018
Q2 | $1.56M | Buy |
15,071
+6,700
| +80% | +$678K | 0.08% | 321 |
|
|
2018
Q1 | $824K | Buy |
8,371
+3,737
| +81% | +$353K | 0.05% | 530 |
|
|
2017
Q4 | $392K | Buy |
4,634
+3,167
| +216% | +$262K | 0.02% | 1063 |
|
|
2017
Q3 | $113K | Buy |
+1,467
| New | +$112K | 0.01% | 1603 |
|
|
2017
Q2 | – | Sell |
-8,273
| Closed | -$595K | – | 1851 |
|
|
2017
Q1 | $595K | Buy |
+8,273
| New | +$572K | 0.04% | 565 |
|
|
2016
Q4 | – | Sell |
-21,082
| Closed | -$1.37M | – | 1856 |
|
|
2016
Q3 | $1.37M | Buy |
21,082
+17,541
| +495% | +$1.17M | 0.09% | 304 |
|
|
2016
Q2 | $224K | Sell |
3,541
-7,178
| -67% | -$423K | 0.01% | 1274 |
|
|
2016
Q1 | $620K | Sell |
10,719
-15,629
| -59% | -$885K | 0.04% | 674 |
|
|
2015
Q4 | $1.42M | Buy |
26,348
+20,562
| +355% | +$1.16M | 0.08% | 331 |
|
|
2015
Q3 | $295K | Sell |
5,786
-2,127
| -27% | -$114K | 0.01% | 1242 |
|
|
2015
Q2 | $446K | Buy |
+7,913
| New | +$499K | 0.02% | 1012 |
|
|
2015
Q1 | – | Sell |
-5,931
| Closed | -$332K | – | 2051 |
|
|
2014
Q4 | $332K | Buy |
+5,931
| New | +$310K | 0.02% | 1141 |
|
|
2014
Q3 | – | Sell |
-3,974
| Closed | -$201K | – | 1853 |
|
|
2014
Q2 | $201K | Buy |
+3,974
| New | +$197K | 0.01% | 1175 |
|
Other funds holding RMD
Cubist Systematic Strategies's RMD Position: Q4 2023 in Review
Cubist Systematic Strategies sold out of ResMed (RMD) in Q4 2023, closing a stake of 11,486 shares — an estimated $1.76M sold.
Cubist Systematic Strategies first reported a position in RMD in Q2 2014 and held it in 32 quarters. The position peaked at $49.2M in Q2 2023. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.
- Cubist Systematic Strategies reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
- Cubist Systematic Strategies sold 11,486 ResMed shares in Q4 2023, an estimated $1.76M.
- Cubist Systematic Strategies first reported a position in ResMed in Q2 2014 and held it in 32 quarters.
- Cubist Systematic Strategies's ResMed position peaked at $49.2M in Q2 2023.
- 687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.
Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.